AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33027827 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners' home visits
Number of subjects: 303
Study 33027827 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of the doctor
Number of subjects: 303
Study 33027827 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional characteristics
Number of subjects: 303
Study 33027827 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate regression analysis
Number of subjects: 303
Study 34127014 — intervention group
Group type: EXPERIMENTAL
Intervention: BA (5.0 g·day‐1 of β‐alanine)
Number of subjects: 9
Study 34127014 — intervention group
Group type: EXPERIMENTAL
Intervention: ALK (0.07 g·kgFFM‐1·day‐1 of sodium bicarbonate)
Number of subjects: 9
Study 34127014 — intervention group
Group type: COMPARATOR
Intervention: BA combined with BCAA and TCM
Number of subjects: 9
Study 34127014 — intervention group
Group type: COMPARATOR
Intervention: ALK combined with BCAA and TCM
Number of subjects: 9
Study 36322882 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone problem-solving therapy and behavioral activation apps
Number of subjects: 447
Study 36322882 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 447
Study 33769540 — intervention group
Group type: EXPERIMENTAL
Intervention: 313‐variant Polygenic Risk Score (PRS313)
Number of subjects: 18434
Study 33769540 — intervention group
Group type: EXPERIMENTAL
Intervention: Recalibrated Polygenic Risk Score
Number of subjects: 18434
Study 32552366 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention to address IPV in pregnant women
Number of subjects: 16
Study 32552366 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of mental health services into primary ANC services
Number of subjects: 16
Study 35124433 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive remediation
Number of subjects: 0
Study 35124433 — intervention group
Group type: COMPARATOR
Intervention: Vocational services alone
Number of subjects: 0
Study 33217221 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic kidney transplant
Number of subjects: 25
Study 33217221 — intervention group
Group type: COMPARATOR
Intervention: Open kidney transplant
Number of subjects: 25
Study 32223587 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine surgery (Group I)
Number of subjects: 87
Study 32223587 — intervention group
Group type: COMPARATOR
Intervention: Postnatal surgery (Group II)
Number of subjects: 87
Study 33244655 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed fluid management
Number of subjects: 60
Study 33244655 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluid treatment
Number of subjects: 60
Study 35290152 — intervention group
Group type: EXPERIMENTAL
Intervention: TV003
Number of subjects: 200
Study 35290152 — intervention group
Group type: EXPERIMENTAL
Intervention: TV005
Number of subjects: 200
Study 35290152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 34936739 — intervention group
Group type: EXPERIMENTAL
Intervention: Spesolimab (900 mg intravenous dose)
Number of subjects: 53
Study 34936739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 34583344 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (single oral dose)
Number of subjects: 301
Study 34583344 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (7-day course)
Number of subjects: 301
Study 33941639 — intervention group
Group type: EXPERIMENTAL
Intervention: s-MoCA-SWE
Number of subjects: 0
Study 32606341 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical mechanical approach for ensembles of time series designed to preserve statistical properties of empirical time series; specific dosage and duration not available.
Number of subjects: 0
Study 32606341 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised, data‐driven framework for hypothesis testing; specific dosage and duration not available.
Number of subjects: 0
Study 34881675 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based intervention
Number of subjects: 374
Study 34881675 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 374
Study 32521100 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 225
Study 33610228 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 425809 10 mg
Number of subjects: 509
Study 33610228 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 425809 25 mg
Number of subjects: 509
Study 33610228 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 425809 2 mg
Number of subjects: 509
Study 33610228 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 425809 5 mg
Number of subjects: 509
Study 33610228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 509
Study 33750085 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation (8 weeks, 5 days/week, daily cost of 74 PLN)
Number of subjects: 0
Study 33750085 — intervention group
Group type: COMPARATOR
Intervention: Standard care (costs from extra in-patient and out-patient rehabilitation)
Number of subjects: 0
Study 32174354 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality headsets
Number of subjects: 27
Study 35273051 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Integrated Health (MIH) intervention which includes home visits from a community paramedic and telehealth video visits by emergency medicine physicians.
Number of subjects: 2100
Study 35273051 — intervention group
Group type: COMPARATOR
Intervention: Transitions of Care Coordinators (TOCC) intervention which consists of follow-up phone calls from a registered nurse within 48-72 hours of discharge.
Number of subjects: 2100
Study 35273051 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Integrated Health (MIH) intervention
Number of subjects: 2100
Study 35273051 — intervention group
Group type: COMPARATOR
Intervention: Transitions of Care Coordinators (TOCC) intervention
Number of subjects: 2100
Study 33136119 — intervention group
Group type: EXPERIMENTAL
Intervention: INT (theory-based lifestyle intervention)
Number of subjects: 1028
Study 33136119 — intervention group
Group type: EXPERIMENTAL
Intervention: INT-DPM (lifestyle intervention with diabetes prevention mentors)
Number of subjects: 1028
Study 33136119 — intervention group
Group type: COMPARATOR
Intervention: CON (usual care)
Number of subjects: 1028
Study 33136119 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions (INT and INT-DPM)
Number of subjects: 1028
Study 33095184 — intervention group
Group type: EXPERIMENTAL
Intervention: SCAMPI program (intervention group)
Number of subjects: 80
Study 33095184 — intervention group
Group type: COMPARATOR
Intervention: Static WeChat page for standard smoking cessation care (control group)
Number of subjects: 80
Study 35706495 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-weeks aerobic exercise training (three sessions per week of 60 min at 60–80% peak heart rate, physical activity self-monitoring, motivational coaching)
Number of subjects: 203
Study 35706495 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-weeks aerobic exercise training
Number of subjects: 203
Study 35706495 — intervention group
Group type: COMPARATOR
Intervention: Control group (educational materials on hypertension and recommended lifestyle behaviours)
Number of subjects: 203
Study 32007641 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal binder
Number of subjects: 66
Study 32007641 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study 33463428 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined ACL reconstruction and ALL suture tape augmentation (Group 2, n=30)
Number of subjects: 63
Study 33463428 — intervention group
Group type: COMPARATOR
Intervention: Isolated ACL reconstruction (Group 1, n=33)
Number of subjects: 63
Study 32736542 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise during chemotherapy
Number of subjects: 0
Study 32736542 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (usual care during chemotherapy and aerobic exercise post-chemotherapy)
Number of subjects: 0
Study 36150312 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga group
Number of subjects: 140
Study 36150312 — intervention group
Group type: COMPARATOR
Intervention: Routine hospital care (control group)
Number of subjects: 140
Study 36263860 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasopharyngeal tube (NPT) insertion
Number of subjects: 45
Study 36263860 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NPT insertion)
Number of subjects: 45
Study 33557019 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluids of different osmolarity and minerals contents
Number of subjects: 14
Study 33557019 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluids of different osmolarity
Number of subjects: 14
Study 33557019 — intervention group
Group type: COMPARATOR
Intervention: Mineralized water
Number of subjects: 14
Study 34842950 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617 (6.0-7.4 GBq/cycle, every 8 weeks, up to 4 cycles)
Number of subjects: 40
Study 34842950 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2/cycle, every 3 weeks, up to 10 cycles)
Number of subjects: 40
Study 34842950 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-PSMA-617
Number of subjects: 40
Study 34842950 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 40
Study 34351460 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cell therapy (180,000 ± 35,000 cells injected)
Number of subjects: 50
Study 34351460 — intervention group
Group type: COMPARATOR
Intervention: Core decompression without cells (control group)
Number of subjects: 50
Study 34242551 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative affect induction
Number of subjects: 150
Study 34242551 — intervention group
Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 150
Study 34242551 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion suppression
Number of subjects: 150
Study 34423625 — intervention group
Group type: EXPERIMENTAL
Intervention: Lever positioning manipulation combined with pulsed electric field
Number of subjects: 58
Study 34423625 — intervention group
Group type: COMPARATOR
Intervention: Pulsed electric field (Control)
Number of subjects: 58
Study 615920838 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral domain optical coherence tomography (SD-OCT)
Number of subjects: 20
Study 35213666 — intervention group
Group type: COMPARATOR
Intervention: Good olfaction (B-SIT score 10-11)
Number of subjects: 2531
Study 35213666 — intervention group
Group type: EXPERIMENTAL
Intervention: Anosmia (score≤6)
Number of subjects: 2531
Study 35213666 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyposmia (7-8)
Number of subjects: 2531
Study 35213666 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory function
Number of subjects: 2531
Study 33968362 — intervention group
Group type: EXPERIMENTAL
Intervention: Sending a pre-notification card
Number of subjects: 558
Study 33968362 — intervention group
Group type: COMPARATOR
Intervention: Not sending a pre-notification card
Number of subjects: 558
Study 32406746 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT) for 12 weeks, n = 12
Number of subjects: 30
Study 32406746 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT) for 16 weeks, n = 10
Number of subjects: 30
Study 32406746 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT) for 20 weeks, n = 8
Number of subjects: 30
Study 33576411 — intervention group
Group type: EXPERIMENTAL
Intervention: SPT from a chair (35 cm seat height)
Number of subjects: 32
Study 33576411 — intervention group
Group type: EXPERIMENTAL
Intervention: SDL using hex-bar
Number of subjects: 32
Study 33544759 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal TDF-ART (Tenofovir disoproxil fumarate / Emtricitabine + Lopinavir/ritonavir)
Number of subjects: 398
Study 33544759 — intervention group
Group type: COMPARATOR
Intervention: Infant nevirapine prophylaxis (no maternal antiretroviral therapy)
Number of subjects: 398
Study 32124574 — intervention group
Group type: EXPERIMENTAL
Intervention: Milieu Therapy and routine hospital treatment
Number of subjects: 100
Study 32124574 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment in the hospital
Number of subjects: 100
Study 35774395 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (200,000 IU intramuscular cholecalciferol)
Number of subjects: 18
Study 35774395 — intervention group
Group type: COMPARATOR
Intervention: Oral vancomycin (control)
Number of subjects: 18
Study 32887851 — intervention group
Group type: COMPARATOR
Intervention: Low load resistance training (LOW, n = 15)
Number of subjects: 29
Study 32887851 — intervention group
Group type: COMPARATOR
Intervention: Moderate load resistance training (MOD, n = 14)
Number of subjects: 29
Study 35319844 — intervention group
Group type: EXPERIMENTAL
Intervention: He's santong acupuncture therapy
Number of subjects: 60
Study 35319844 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 60
Study 32996450 — intervention group
Group type: EXPERIMENTAL
Intervention: Private toilet access
Number of subjects: 2044
Study 32996450 — intervention group
Group type: EXPERIMENTAL
Intervention: Public toilet access
Number of subjects: 2044
Study 32996450 — intervention group
Group type: COMPARATOR
Intervention: No toilet access
Number of subjects: 2044
Study 32996450 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall defecation behavior
Number of subjects: 2044
Study 34276021 — intervention group
Group type: EXPERIMENTAL
Intervention: BigThumb Group (BT Group)
Number of subjects: 218
Study 34276021 — intervention group
Group type: COMPARATOR
Intervention: Traditional Follow-up Group (TF Group)
Number of subjects: 218
Study 34276021 — intervention group
Group type: EXPERIMENTAL
Intervention: AI algorithm
Number of subjects: 218
Study 33124506 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified Oral Hygiene Care (IOHC)
Number of subjects: 0
Study 33124506 — intervention group
Group type: COMPARATOR
Intervention: Routine Oral Hygiene Care (Control)
Number of subjects: 0
Study 37948286 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision nutrition counseling (six weekly sessions)
Number of subjects: 138
Study 37948286 — intervention group
Group type: COMPARATOR
Intervention: Control group (educational pamphlets)
Number of subjects: 138
Study 37948286 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall subjects (both groups)
Number of subjects: 138
Study 37948286 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth application
Number of subjects: 138
Study 37948286 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision nutrition counseling
Number of subjects: 138
Study 37948286 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA-based nutrition counseling
Number of subjects: 138
Study 33064852 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal misoprostol (preoperative)
Number of subjects: 98
Study 33064852 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine misoprostol (intraoperative)
Number of subjects: 98
Study 32406112 — intervention group
Group type: EXPERIMENTAL
Intervention: linaclotide (290 µg)
Number of subjects: 39
Study 32406112 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 39
Study 36029502 — intervention group
Group type: EXPERIMENTAL
Intervention: CLCG group
Number of subjects: 200
Study 36029502 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild CLCG group
Number of subjects: 200
Study 32145794 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus cetuximab
Number of subjects: 0
Study 32145794 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy plus cisplatin
Number of subjects: 0
Study 33909985 — intervention group
Group type: EXPERIMENTAL
Intervention: RemindMe (interactive digital calendar with mobile phone reminders)
Number of subjects: 15
Study 33909985 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment by an occupational therapist
Number of subjects: 15
Study 33008264 — intervention group
Group type: EXPERIMENTAL
Intervention: CRVO patients
Number of subjects: 95
Study 34215235 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First (HF)
Number of subjects: 703
Study 34215235 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 703
Study 32441183 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudes, self-efficacy, habits, and intention
Number of subjects: 332
Study 32441183 — intervention group
Group type: EXPERIMENTAL
Intervention: Women who did not want to quit hookah
Number of subjects: 332
Study 32441183 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge and Social norms
Number of subjects: 332
Study 34995417 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3640254 tablet formulation 200 mg
Number of subjects: 39
Study 34995417 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3640254 tablet formulation 200 mg under high-fat conditions
Number of subjects: 39
Study 34291981 — intervention group
Group type: EXPERIMENTAL
Intervention: Black Atheist
Number of subjects: 343
Study 34291981 — intervention group
Group type: COMPARATOR
Intervention: Black Christian
Number of subjects: 343
Study 34291981 — intervention group
Group type: COMPARATOR
Intervention: Unknown religious affiliation
Number of subjects: 343
Study 33155849 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac emulgel
Number of subjects: 15000
Study 33155849 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen gel
Number of subjects: 15000
Study 33155849 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen gel
Number of subjects: 15000
Study 33155849 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac (any formulation)
Number of subjects: 15000
Study 33155849 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 15000
Study 35742721 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction and cognitive engagement-based blended teaching
Number of subjects: 0
Study 35742721 — intervention group
Group type: COMPARATOR
Intervention: Usual teaching
Number of subjects: 0
Study 32940336 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-H pylori treatment
Number of subjects: 27
Study 32940336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 32762637 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation program (letter followed by a phone call from navigators)
Number of subjects: 251
Study 32762637 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation program (among 56 intervention patients who received navigation)
Number of subjects: 251
Study 32762637 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation program (in subgroup of patients with SUD)
Number of subjects: 251
Study 32762637 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 251
Study 34342035 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib before daratumumab (Car‐Da)
Number of subjects: 635
Study 34342035 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab after carfilzomib (Da‐Car)
Number of subjects: 635
Study 34342035 — intervention group
Group type: COMPARATOR
Intervention: Daratumumab (used before or after carfilzomib)
Number of subjects: 635
Study 33161736 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Bacillus subtilis DE111)
Number of subjects: 100
Study 35859408 — intervention group
Group type: EXPERIMENTAL
Intervention: One shade universal composite, Omnichroma
Number of subjects: 25
Study 34687253 — intervention group
Group type: EXPERIMENTAL
Intervention: LL-37 at 0.5 mg/mL
Number of subjects: 148
Study 34687253 — intervention group
Group type: EXPERIMENTAL
Intervention: LL-37 at 1.6 mg/mL
Number of subjects: 148
Study 34687253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 34687253 — intervention group
Group type: EXPERIMENTAL
Intervention: LL-37 (both concentrations) in subgroup with large target wounds (≥10 cm2)
Number of subjects: 148
Study 35172856 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline implementation (active implementation of an evidence-based feeding guideline)
Number of subjects: 2772
Study 35172856 — intervention group
Group type: COMPARATOR
Intervention: Control group (no awareness of guideline content)
Number of subjects: 2772
Study 34428542 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG IFN-α2b + SOC
Number of subjects: 250
Study 34428542 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 250
Study 33530828 — intervention group
Group type: EXPERIMENTAL
Intervention: Notched peripheral intravenous catheter
Number of subjects: 658
Study 33530828 — intervention group
Group type: COMPARATOR
Intervention: Traditional non-notched catheter
Number of subjects: 658
Study 34479071 — intervention group
Group type: EXPERIMENTAL
Intervention: Municipality-based intervention (n=1,545)
Number of subjects: 3103
Study 34479071 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based intervention (n=1,558)
Number of subjects: 3103
Study 34479071 — intervention group
Group type: EXPERIMENTAL
Intervention: Municipality-based intervention
Number of subjects: 3103
Study 34479071 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based intervention
Number of subjects: 3103
Study 35778714 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate plus placebo
Number of subjects: 775
Study 34366941 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative pop-up messages
Number of subjects: 58
Study 34366941 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-appraisal pop-ups
Number of subjects: 58
Study 34366941 — intervention group
Group type: COMPARATOR
Intervention: Blank pop-up messages
Number of subjects: 58
Study 32473033 — intervention group
Group type: EXPERIMENTAL
Intervention: Active ingredients from Angelicae Pubescentis Radix (AP) identified through spectrum–effect relationship method.
Number of subjects: 0
Study 35575427 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Parenting Program to Promote Child Development (experimental group)
Number of subjects: 60
Study 35575427 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 60
Study 34848294 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-facilitated antibiotic timeout
Number of subjects: 288
Study 34848294 — intervention group
Group type: COMPARATOR
Intervention: Control services
Number of subjects: 288